Skip to main content
. 2021 May 12;10(10):2085. doi: 10.3390/jcm10102085

Table 2.

Significance of pain reduction at four stages and total pain reduction in Bifluorid 10 and Futurabond U groups and difference between groups according to VAS. Positive value of t-statistic in “Difference” row indicates a higher efficacy of Bifluorid 10, negative values of Futurabond U.

Pain Reduction By Stage Total Pain Reduction (T0–T4)
T0–T1 T1–T2 T2–T3 T3–T4
Bifluorid 10 Mean 1.322 0.900 0.778 0.689 3.689
t-statistic 10.54 9.39 7.29 4.47 19.73
p-value <0.001 * <0.001 * <0.001 * <0.001 * <0.001 *
Futurabond U Mean 1.363 0.688 0.763 0.125 2.938
t-statistic 8.81 6.99 7.20 1.13 16.31
p <0.001 * <0.001 * <0.001 * 0.259 <0.001 *
Difference t-statistic −0.20 1.55 0.10 2.97 2.89
p-value 0.840 0.123 0.919 0.003* 0.004 *

*—characteristic significant at 0.05 level.